Company Filing History:

13 out of 888

Institut Pasteur

patents

2 out of 1,799

National Institute of Health and Medical Research

where one patent can have more than one assignee

Years Active: 1997-2013

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8404250 - Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation (2013-03-26),

2. 7871627 - Gram positive bacteria preparations for the treatment of disease comprising an immune dysregulation (2011-01-18),

3. 7658929 - Immunogenic glycopeptides, screening, preparation and uses (2010-02-09),

4. 7361348 - Immunogenic glycopeptides, screening, preparation and uses (2008-04-22),

5. 7101555 - Mycobacterial proteins, microorganisms producing them and their use for vaccines and the detection of tuberculosis (2006-09-05),

6. 6676945 - Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis (2004-01-13),

7. 6379902 - Mycrobacterial proteins, microorganisms producing same and uses of said proteins in vaccines and for detecting tuberculosis (2002-04-30),

8. 6335181 - Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis (2002-01-01),

9. 6221353 - Antibodies Which Bind Mycobacterial Tuberculosis Proteins (2001-04-24),

10. 6060259 - Mycobacterium proteins and applications (2000-05-09),

11. 5962240 - Mycobacterium proteins and applications (1999-10-05),

12. 5866130 - Mycobacterial proteins, microorganisms producing them and their use for (1999-02-02),

13. 5714593 - DNA from mycobacterium tuberculosis which codes for a 45/47 kilodalton (1998-02-03),

14. 5599541 - Peptide sequence capable of inducing a delayed-type hypersensitivity (1997-02-04),

Title: The Innovative Mind of Felix Romain: A Pioneer in Bacterial Therapies

Introduction

Felix Romain, based in Fontenay les Briis, France, is a prominent inventor known for his groundbreaking research and developments in the field of immunology. With a remarkable portfolio of 14 patents, he has made significant contributions to the treatment of diseases related to immune dysregulation. His innovative work continues to inspire advancements in medical science.

Latest Patents

Romain's latest patents focus on preparations derived from Gram-positive bacteria aimed at treating diseases associated with immune dysregulation. One of his notable applications is dedicated to compositions that include Gram-positive facultative intracellular bacteria, which contribute to the treatment of various disorders in both humans and animals. These disorders include serious conditions such as cancer, autoimmune diseases, allergies, and tuberculosis. His dedicated research on extended freeze-dried killed Gram-positive bacteria highlights his commitment to finding effective treatments and preventive measures for complex health challenges.

Career Highlights

Throughout his career, Felix Romain has collaborated with prestigious institutions, most notably Institut Pasteur and the Institut National De La Santé Et De La Recherche Médicale. His experiences at these esteemed organizations have significantly influenced his research methodologies and innovation capabilities. Romain’s work has been pivotal in bridging the gap between laboratory research and practical medical applications.

Collaborations

Romain has worked alongside notable colleagues, such as Gilles Marchal and Pascale Pescher. These collaborations have fostered a rich environment for exchanging ideas and enhancing the development of innovative medical solutions. Together, they have contributed to advancing methods for combating immune-related disorders.

Conclusion

Felix Romain's extensive patent portfolio and collaborative efforts place him at the forefront of innovations in immunological health. His dedicated approach to researching Gram-positive bacteria as therapeutic agents reflects a significant stride toward understanding and treating immune dysregulation. As he continues to explore new frontiers in this field, Romain remains a key figure in the evolution of medical science and therapeutic innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com